SCHEMBL30208559

SCHEMBL30208559

N=C(N)NCC/C=C/C(=O)Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.54
▸ TAS1R3 Q7RTX0 1/20 0.51
▸ TAS1R1 Q7RTX1 1/20 0.51
▸ ADORA2A P29274 4/20 0.48
▸ ADORA3 P0DMS8 3/20 0.48
▸ ADORA1 P30542 2/20 0.48
▸ PAX8 Q06710 1/20 0.47
▸ KRAS P01116 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ PGK1 P00558 1/20 0.44
▸ PGK2 P07205 1/20 0.44
▸ HINT1 P49773 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30208557 0.86 POLA1 (0.52) TAS1R3TAS1R1
SCHEMBL30208535 0.84 HPGD (0.54) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL30208450 0.83 HPGD (0.54) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL30208628 0.83 LMNA (0.54) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL382557 0.79 TAS1R3 (0.77) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL413506 0.79 TAS1R3 (0.77) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL382556 0.79 TAS1R3 (0.77) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL30208547 0.79 HPGD (0.60) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL30208614 0.78 HPGD (0.59) HPGDTAS1R3TAS1R1ADORA2AADORA3
SCHEMBL26246701 0.77 HPGD (0.66) HPGDTAS1R3TAS1R1ADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001982-A1 MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION UNIVERSITÄT BASEL (CH) 2023-01-26 — — WO claimed
WO-2023001982-A1 MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION UNIVERSITÄT BASEL (CH) 2023-01-26 — — WO disclosed
Send feedback